CY1123712T1 - Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας - Google Patents

Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας

Info

Publication number
CY1123712T1
CY1123712T1 CY20201101121T CY201101121T CY1123712T1 CY 1123712 T1 CY1123712 T1 CY 1123712T1 CY 20201101121 T CY20201101121 T CY 20201101121T CY 201101121 T CY201101121 T CY 201101121T CY 1123712 T1 CY1123712 T1 CY 1123712T1
Authority
CY
Cyprus
Prior art keywords
active substance
administration
therapeutic system
layer
transcutaneous therapeutic
Prior art date
Application number
CY20201101121T
Other languages
English (en)
Inventor
Britta Langer
Bjoern Schurad
Heike Prinz
Original Assignee
Luye Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Ag filed Critical Luye Pharma Ag
Publication of CY1123712T1 publication Critical patent/CY1123712T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά ένα διαδερμικό θεραπευτικό σύστημα για την χορήγηση μιας δραστικής ουσίας μέσω του δέρματος που είναι κατάλληλο για χρονικό διάστημα εφαρμογής τουλάχιστον τριών ημερών, το οποίο περιλαμβάνει τις τοποθετημένες με την ακόλουθη σειρά μεταξύ τους στοιβάδες: a) μια στοιβάδα επικάλυψης, b) μια στοιβάδα δραστικής ουσίας, η οποία περιλαμβάνει μια πολυμερική μήτρα που περιέχει τη δραστική ουσία, c) μια συγκολλητική στοιβάδα που περιλαμβάνει μια κόλλα επαφής, η οποία αποτελείται από ένα μείγμα από ένα ή περισσότερα πολυισοβουτυλένια και ένα ή περισσότερα πολυβουτένια, και d) μια αφαιρούμενη στοιβάδα.
CY20201101121T 2010-12-14 2020-11-25 Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας CY1123712T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10194968.3A EP2468274B1 (de) 2010-12-14 2010-12-14 Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
PCT/EP2011/072812 WO2012080365A1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs
EP11799413.7A EP2651410B1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs

Publications (1)

Publication Number Publication Date
CY1123712T1 true CY1123712T1 (el) 2022-03-24

Family

ID=43836835

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20151100738T CY1116638T1 (el) 2010-12-14 2015-08-25 Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
CY20201101121T CY1123712T1 (el) 2010-12-14 2020-11-25 Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20151100738T CY1116638T1 (el) 2010-12-14 2015-08-25 Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας

Country Status (25)

Country Link
US (2) US10660863B2 (el)
EP (2) EP2468274B1 (el)
JP (1) JP6043296B2 (el)
KR (1) KR101842309B1 (el)
CN (3) CN107412202A (el)
AU (2) AU2011343363B2 (el)
BR (1) BR112013014616B1 (el)
CA (2) CA3065240C (el)
CY (2) CY1116638T1 (el)
DK (2) DK2468274T3 (el)
EA (1) EA026520B1 (el)
ES (2) ES2545094T3 (el)
HK (1) HK1243336A1 (el)
HR (2) HRP20150881T1 (el)
HU (2) HUE027916T2 (el)
LT (1) LT2651410T (el)
MX (1) MX345344B (el)
MY (1) MY183873A (el)
PL (2) PL2468274T3 (el)
PT (2) PT2468274E (el)
RS (2) RS54173B1 (el)
SI (2) SI2468274T1 (el)
SM (1) SMT201500184B (el)
WO (1) WO2012080365A1 (el)
ZA (1) ZA201303965B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012000369A1 (de) * 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de) * 2012-08-14 2014-02-20 Jenabatteries GmbH Redox-Flow-Zelle zur Speicherung elektrischer Energie
CN104582693A (zh) * 2012-08-15 2015-04-29 道康宁公司 多层药物递送系统
WO2014111790A2 (en) * 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
JP6864968B2 (ja) 2016-08-22 2021-04-28 救急薬品工業株式会社 貼付剤
JP7193863B2 (ja) * 2017-07-19 2022-12-21 帝國製薬株式会社 リバスチグミン含有経皮吸収型製剤
DE102018120505A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
EP3764998A1 (en) * 2018-03-13 2021-01-20 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
WO2019220697A1 (ja) * 2018-05-17 2019-11-21 パナソニックＩｐマネジメント株式会社 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法
DK3513965T3 (da) 2018-08-08 2022-07-25 Danapak Flexibles As Forbedrede film og laminater til anvendelse i pakning af reaktive forbindelser
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
BR112021023509A2 (pt) * 2019-07-09 2022-01-18 Lts Lohmann Therapie Systeme Ag Sistema terapêutico transdérmico compreendendo uma camada contendo o agente ativo compreendendo um polímero acrílico e uma camada de contato com a pele compreendendo um adesivo de gel de silicone
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
WO1994004109A1 (en) * 1992-08-25 1994-03-03 Cygnus Therapeutic Systems Printed transdermal drug delivery device
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141652B4 (de) 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP2397124A1 (en) * 2004-10-21 2011-12-21 Durect Corporation Transdermal delivery systems
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2007076862A1 (en) * 2005-12-30 2007-07-12 Coloplast A/S A layered adhesive construct having a mouldable layer as skin contact surface
CN101304735A (zh) * 2006-01-12 2008-11-12 Lts勒曼治疗系统股份公司 用于挥发性和/或热不稳定的物质的经皮治疗体系
CA2651596C (en) * 2006-05-08 2014-03-25 Teikoku Seiyaku Co., Ltd. Percutaneous absorption preparations of antidementia drugs
US9248104B2 (en) 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
US20100292660A1 (en) 2007-07-10 2010-11-18 Agis Kydonieus Dermal delivery device with ultrasonic weld
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
ES2661767T3 (es) * 2008-02-27 2018-04-03 Hisamitsu Pharmaceutical Co., Inc. Parche adhesivo para la piel y producto envasado
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
PL2515886T3 (pl) * 2009-12-22 2018-08-31 Luye Pharma Ag Przezskórny układ terapeutyczny do podawania rywastygminy lub jej pochodnych

Also Published As

Publication number Publication date
CA2817461A1 (en) 2012-06-21
HUE027916T2 (en) 2016-11-28
JP6043296B2 (ja) 2016-12-14
CY1116638T1 (el) 2017-03-15
CN113244199A (zh) 2021-08-13
KR101842309B1 (ko) 2018-03-26
ES2545094T3 (es) 2015-09-08
EA026520B1 (ru) 2017-04-28
CA3065240A1 (en) 2012-06-21
CA2817461C (en) 2020-02-25
HRP20150881T1 (hr) 2015-09-25
DK2468274T3 (en) 2015-08-31
RS54173B1 (en) 2015-12-31
KR20130129988A (ko) 2013-11-29
PL2651410T3 (pl) 2021-03-08
EA201300704A1 (ru) 2014-01-30
HRP20201880T1 (hr) 2021-02-05
HK1243336A1 (zh) 2018-07-13
EP2468274A1 (de) 2012-06-27
MX2013005581A (es) 2013-08-26
MY183873A (en) 2021-03-17
AU2011343363A1 (en) 2013-06-20
ES2836483T3 (es) 2021-06-25
DK2651410T3 (da) 2020-11-02
HUE052137T2 (hu) 2021-04-28
CN103269698A (zh) 2013-08-28
EP2468274B1 (de) 2015-07-01
SI2651410T1 (sl) 2021-01-29
US20200289426A1 (en) 2020-09-17
US20140323996A1 (en) 2014-10-30
PT2468274E (pt) 2015-09-21
MX345344B (es) 2017-01-26
PT2651410T (pt) 2020-12-15
ZA201303965B (en) 2014-09-25
EP2651410B1 (de) 2020-10-14
RS61155B1 (sr) 2020-12-31
CN103269698B (zh) 2017-07-14
CN107412202A (zh) 2017-12-01
BR112013014616A2 (pt) 2016-09-20
CA3065240C (en) 2022-02-15
AU2011343363B2 (en) 2017-06-08
JP2014503523A (ja) 2014-02-13
EP2651410A1 (de) 2013-10-23
AU2017213569B2 (en) 2019-04-11
BR112013014616B1 (pt) 2021-12-21
WO2012080365A1 (de) 2012-06-21
SMT201500184B (it) 2015-09-07
LT2651410T (lt) 2020-12-28
PL2468274T3 (pl) 2015-11-30
US10660863B2 (en) 2020-05-26
AU2017213569A1 (en) 2017-08-31
SI2468274T1 (sl) 2015-10-30

Similar Documents

Publication Publication Date Title
CY1123712T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
CY1120283T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης
BR112012024835A2 (pt) adesivo de distribuição transdérmica
CL2015003377A1 (es) Sistema de liberación transdérmico.
CY1117770T1 (el) Διαδερμικο θεραπευτικο συστημα για χορηγηση της δραστικης ουσιας βουπρενορφινη
CR20150360A (es) Sistema de liberación transdérmica
CY1116111T1 (el) Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης
WO2012124966A3 (ko) 펜타닐 경피 패치제
MY163809A (en) Transdermal drug delivery system containing donepezil
HK1143301A1 (en) Apparatus for the formation of multiple microconduits
EA201400628A1 (ru) Трансдермальная терапевтическая система для введения фентанила или его аналога
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
IN2012DN01225A (el)
BR112012001349B8 (pt) processo livre de solvente para produzir uma composição adesiva
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
MX2012008381A (es) Tira dental para administracion de tratamiento oral.
AR095258A1 (es) Composiciones transdérmicas de metilfenidato con adhesivos a base de goma
DE112008002414A5 (de) Reservoirsystem mit verschlossener Membran
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
PH12015500200A1 (en) Transdermal formulation containing cox inhibitors
WO2016149077A3 (en) Fentanyl transdermal delivery system
BR112012014107A2 (pt) sistema terapêutico transdérmico para administração de peptídeos
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
EA201391023A1 (ru) Способ снижения боли у животных семейства собачьих с помощью трансдермального раствора фентанила